Zetter B R
Department of Physiology, Harvard Medical School and Children's Hospital, Boston, MA 02115.
Semin Cancer Biol. 1993 Aug;4(4):219-29.
It is now clear that adhesive interactions play a critical role in the process of metastatic tumor dissemination. Adhesion molecules act as both positive and negative modulators of the metastatic process. Molecules such as E-cadherin that promote homotypic tumor cell adhesion function to maintain intercellular contacts that confine cells to the primary tumor site and are negatively correlated with metastatic potential. Because tumor cells are rapidly eliminated from the circulation, those cells that can quickly arrest in the vasculature at a secondary site and pass through the vessel wall into the surrounding tissue will have a selective advantage toward establishing new metastatic colonies. The first step in this process is specific adhesion to venular endothelial cells in selected organs, a process mediated by tumor cell surface molecules such as Sialyl LewisX or the VLA-4 (alpha 4 beta 1) integrin that mediate binding to endothelial adhesion molecules such as the E-selectin or the vascular cell adhesion molecule, VCAM-1. Site-specific endothelial determinants such as the lung endothelial cell adhesion molecule, LuECAM, may additionally specify particular sites for preferential adhesion and subsequent site-specific metastasis of particular tumor types. After adherence to endothelial cells and subsequent endothelial retraction, metastatic tumor cells must adhere to elements of the subendothelial basement membrane such as laminin and types IV and V collagen, interactions frequently mediated by members of the beta 1 and beta 4 integrin families. Finally, metastatic tumor cell adhesion to connective tissue elements such as fibronectin, type I collagen and hyaluronan, mediated by molecules such as the beta 1 integrins and by the CD44 cell surface adhesion molecule, are required for movement of tumor cells into the subendothelial stroma and subsequent growth at these new sites. Thus, metastatic potential can be influenced both positively and negatively by a variety of cell surface adhesive molecules that act both independently and in concert to direct tumor cells to particular tissues, allowing them to arrest in those tissues, migrate across the vessel wall and grow at the secondary site. In the current review, I discuss the nature of the adhesion molecules that have been implicated in the metastatic process, emphasizing those molecules that have been shown to correlate with metastasis in clinical human tumors or that have been shown to influence metastatic potential in in vivo experimental assays.
现在已经清楚,黏附相互作用在转移性肿瘤播散过程中起着关键作用。黏附分子在转移过程中既作为正向调节因子,也作为负向调节因子。诸如E-钙黏蛋白等促进同型肿瘤细胞黏附的分子,其功能是维持细胞间接触,将细胞限制在原发肿瘤部位,并且与转移潜能呈负相关。由于肿瘤细胞会迅速从循环中清除,那些能够在二级部位的脉管系统中迅速停滞并穿过血管壁进入周围组织的细胞,在建立新的转移瘤灶方面将具有选择性优势。这个过程的第一步是肿瘤细胞与特定器官的小静脉内皮细胞特异性黏附,这一过程由肿瘤细胞表面分子介导,如唾液酸化路易斯X或VLA-4(α4β1)整合素,它们介导与内皮黏附分子如E-选择素或血管细胞黏附分子VCAM-1的结合。特定部位的内皮决定因素,如肺内皮细胞黏附分子LuECAM,可能还会为特定肿瘤类型的优先黏附及随后的部位特异性转移指定特定部位。在黏附于内皮细胞并随后内皮细胞收缩后,转移性肿瘤细胞必须黏附于内皮下基底膜的成分,如层粘连蛋白以及IV型和V型胶原,这些相互作用通常由β1和β4整合素家族成员介导。最后,转移性肿瘤细胞与结缔组织成分如纤连蛋白、I型胶原和透明质酸的黏附,由诸如β1整合素和CD44细胞表面黏附分子等分子介导,这是肿瘤细胞进入内皮下基质并在这些新部位随后生长所必需的。因此,多种细胞表面黏附分子可对转移潜能产生正向和负向影响,这些分子既独立发挥作用,也协同作用,将肿瘤细胞导向特定组织,使其在这些组织中停滞、穿过血管壁并在二级部位生长。在本综述中,我将讨论与转移过程相关的黏附分子的性质,重点关注那些已被证明与临床人类肿瘤转移相关或在体内实验分析中已被证明会影响转移潜能的分子。